You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adenocarcinoma of the gastro-esophageal

Showing 1 - 25 of 5,195
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric or Gastro-esophageal Junction (GEJ) or Esophageal Adenocarcinoma (EAC) Trial in Poland, Spain, United States (NT-I7,

Active, not recruiting
  • Gastric or Gastro-esophageal Junction (GEJ) or Esophageal Adenocarcinoma (EAC)
  • Louisville, Kentucky
  • +5 more
Dec 7, 2022

Stomach Tumors Trial in Wuhan (Fruquintinib, Sintilimab)

Not yet recruiting
  • Stomach Neoplasms
  • Wuhan, Hubei, China
    Wuhan Union Hospital, China
Nov 22, 2022

Advanced Gastric and Gastro-esophageal Junction Adenocarcinoma Trial in Beijing (sintilimab, nab-paclitaxel)

Recruiting
  • Advanced Gastric and Gastro-esophageal Junction Adenocarcinoma
  • Beijing, China
    Chinese Academy of Medical Sciences
Mar 9, 2022

Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma Trial in Guangzhou (zolbetuximab)

Completed
  • Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
  • Guangzhou, China
    Site CN86001
Jan 11, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Beijing (CS1001 mAb, CS1001 , Oxaliplatin)

Active, not recruiting
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • CS1001 monoclonal antibody
  • +3 more
  • Beijing, China
    Beijing Cancer Hospital
Sep 27, 2022

Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Gastric Cardia Trial in

Active, not recruiting
  • Adenocarcinoma of the Esophagus
  • +5 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jul 25, 2022

Gastro-Esophageal Junction Adenocarcinoma, Gastric Cancer Trial in United States (Nab-paclitaxel 150 mg/m^2, Oxaliplatin 85

Active, not recruiting
  • Gastro-Esophageal Junction Adenocarcinoma
  • Gastric Cancer
  • Nab-paclitaxel 150 mg/m^2
  • +3 more
  • Chicago, Illinois
  • +7 more
Feb 16, 2022

Gastrointestinal Cancer, Colorectal Cancer, Pancreatic Adenocarcinoma Trial in Stanford (Serious Illness Conversation Guide

Terminated
  • Gastrointestinal Cancer
  • +8 more
  • Serious Illness Conversation Guide (SICG)
  • Quality of Life (QOL) survey
  • Stanford, California
    Stanford Cancer Center
Jan 25, 2023

Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8, Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage

Recruiting
  • Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
  • +85 more
  • Patient Monitoring System
  • +2 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Sep 7, 2022

Gastric Cancer, Gastro-esophageal Junction Cancer, Pancreatic Ductal Adenocarcinoma Trial in Worldwide (AZD5863)

Recruiting
  • Gastric Cancer
  • +3 more
  • Jacksonville, Florida
  • +16 more
Aug 17, 2023

Adenocarcinoma Trial in Chicago (Trastuzumab, ABT-806, Bemarituzumab)

Completed
Has Results
  • Adenocarcinoma
  • Chicago, Illinois
    University of Chicago
Mar 15, 2021

Gastric Cancer, Gastro-esophageal Junction (GEJ) Cancer Trial in Kashiwa (Zolbetuximab)

Completed
  • Gastric Cancer
  • Gastro-esophageal Junction (GEJ) Cancer
  • Kashiwa, Chiba, Japan
    Site JP00001
Mar 3, 2021

Relapsed or Advanced Gastric Adenocarcinoma, Gastro-esophageal Junction Cancer Trial in Seoul (autologous activated T

Recruiting
  • Relapsed or Advanced Gastric Adenocarcinoma
  • Gastro-esophageal Junction Cancer
  • autologous activated T lymphocyte
  • Seoul, Korea, Republic of
    Gangnam Severacen Hospital
Sep 15, 2021

Squamous Cell Carcinoma, Adenocarcinoma, Esophageal Cancer Trial in Amsterdam (Carboplatin, Paclitaxel, panitumumab)

Completed
  • Squamous Cell Carcinoma
  • +3 more
  • Amsterdam, Netherlands
    Academic Medical Center
Apr 19, 2021

Barrett Esophagus Adenocarcinoma Trial in Marseille (Complete endoscopic resection at Day 1 and months 2, 4, 6 8 and month 10.,

Recruiting
  • Barrett Esophagus Adenocarcinoma
  • Complete endoscopic resection at Day 1 and months 2, 4, 6 8 and month 10.
  • Endoscopic resection at month 2 and month 4
  • Marseille, France
    GENRE
May 5, 2021

Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Chuo Ku (TRK-950, Ramucirumab,

Not yet recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • TRK-950
  • +2 more
  • Chuo Ku, Japan
    Osaka International Cancer Institute
Sep 14, 2023

Gastric Cancer, Gastro Esophageal Junctional Cancer, Cancer Trial (68Ga-FAPi-46)

Not yet recruiting
  • Gastric Cancer
  • +2 more
  • (no location specified)
Jun 12, 2023

Metastatic Gastric Cancer, Adenocarcinoma of the Gastro-oesophageal Junction Trial in Amsterdam (Docetaxel, Oxaliplatin,

Active, not recruiting
  • Metastatic Gastric Cancer
  • Adenocarcinoma of the Gastro-oesophageal Junction
  • Docetaxel, Oxaliplatin, Capecitabin, Bevacizumab
  • Docetaxel, Oxaliplatin, Capecitabin, Bevacizumab, Trastuzumab
  • Amsterdam, Netherlands
    Netherlands Cancer Institute
Jan 26, 2021

Hiatus Hernia in Gastro-Esophageal Reflux Disease Patients

Not yet recruiting
  • Hiatus Hernia
  • Upper Endoscopy
  • (no location specified)
Nov 24, 2023

Metastatic Gastro-esophageal Adenocarcinoma Trial in Regina, Saskatoon (FOLFOX and FOLFIRI)

Terminated
  • Metastatic Gastro-esophageal Adenocarcinoma
  • FOLFOX and FOLFIRI
  • Regina, Saskatchewan, Canada
  • +1 more
Oct 29, 2020

Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach Trial in

Terminated
Has Results
  • Adenocarcinoma of the Esophagus
  • +13 more
  • oblimersen sodium
  • +2 more
  • Bronx, New York
    Montefiore Medical Center
Jan 29, 2021

Barrett's Esophagus and Esophageal Adenocarcinoma, Searching for

Recruiting
  • Esophageal Neoplasms
    • Ghent, Oost-Vlaanderen, Belgium
      University hospital Ghent
    Jan 13, 2023

    Tissue Collection Protocol for Gastroesophageal Cancers

    Recruiting
    • Esophageal Cancer
    • Tissue Collection
    • Toronto, Ontario, Canada
      University Health Network: Toronto General Hospital
    Apr 8, 2022

    Adenocarcinoma Esophagus, Locally Advanced Adenocarcinoma, Siewert Type I Adenocarcinoma of Esophagogastric Junction Trial

    Not yet recruiting
    • Adenocarcinoma Esophagus
    • +3 more
    • (no location specified)
    Sep 13, 2023

    Gastric Cancer Trial in Philadelphia (Neratinib Pill, Fam-Trastuzumab Deruxtecan-Nxki (TDxD))

    Suspended
    • Gastric Cancer
    • Neratinib Pill
    • Fam-Trastuzumab Deruxtecan-Nxki (TDxD)
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center
    Jul 6, 2022